Primary endpoint analysis of the multicentre phase II hypo-FLAME trial for intermediate and high risk prostate cancer

C Draulans, UA van der Heide, K Haustermans… - Radiotherapy and …, 2020 - Elsevier
Background and purpose Local recurrences after radiotherapy for prostate cancer (PCa)
often originate at the location of the macroscopic tumour (s). Since PCa cells are known to …

Primary endpoint analysis of the multicentre phase II hypo-FLAME trial for intermediate and high risk prostate cancer

C Draulans, UA van der Heide… - Radiotherapy and …, 2020 - thegreenjournal.com
Background and purpose Local recurrences after radiotherapy for prostate cancer (PCa)
often originate at the location of the macroscopic tumour (s). Since PCa cells are known to …

Primary endpoint analysis of the multicentre phase II hypo-FLAME trial for intermediate and high risk prostate cancer.

C Draulans, UA van der Heide… - … Oncology: Journal of …, 2020 - europepmc.org
Background and purpose Local recurrences after radiotherapy for prostate cancer (PCa)
often originate at the location of the macroscopic tumour (s). Since PCa cells are known to …

Primary endpoint analysis of the multicentre phase II hypo-FLAME trial for intermediate and high risk prostate cancer

C Draulans, UA van der Heide… - … : journal of the …, 2020 - pubmed.ncbi.nlm.nih.gov
Background and purpose Local recurrences after radiotherapy for prostate cancer (PCa)
often originate at the location of the macroscopic tumour (s). Since PCa cells are known to …

Primary endpoint analysis of the multicentre phase II hypo-FLAME trial for intermediate and high risk prostate cancer

C Draulans, UA van der Heide… - Radiotherapy And …, 2020 - lirias.kuleuven.be
BACKGROUND AND PURPOSE: Local recurrences after radiotherapy for prostate cancer
(PCa) often originate at the location of the macroscopic tumour (s). Since PCa cells are …